According to the results of pathway enrichment, we believe that effects of FGHP against CHD may be due to the fact that FGHP can simultaneously target multiple pathways like pathways in cancer, HIF-1 signaling pathway, PPAR signaling pathway, TNF signaling pathway, and so on (shown in Figure 2(b)). This evidence concerns the gene PPARA and coronary artery disorder.